ChemicalBook > CAS DataBase List > RILMENIDINE HEMIFUMARATE SALT

RILMENIDINE HEMIFUMARATE SALT

Product Name
RILMENIDINE HEMIFUMARATE SALT
CAS No.
207572-68-7
Chemical Name
RILMENIDINE HEMIFUMARATE SALT
Synonyms
LZFATBMLSYHRTC-WXXKFALUSA-N;RILMENIDINE HEMIFUMARATE SALT;n-(dicyclopropylmethyl)-4,5-dihydro-2-oxazolamine hemifumarate salt;Oxaminozoline hemifumarate salt, Rilmenidene hemifumarate salt, N-(Dicyclopropylmethyl)-4,5-dihydro-2-oxazolamine hemifumarate salt
CBNumber
CB5972920
Molecular Formula
2C10H16N2O.C4H4O4
Formula Weight
476.57
MOL File
207572-68-7.mol
More
Less

RILMENIDINE HEMIFUMARATE SALT Property

storage temp. 
Store at -20°C
solubility 
DMSO: >10mg/mL
form 
solid
color 
white
More
Less

Safety

Safety Statements 
22-24/25
WGK Germany 
3
RTECS 
RP7207400
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
R134
Product name
Rilmenidine hemifumarate salt
Purity
solid
Packaging
5mg
Price
$148
Updated
2024/03/01
Sigma-Aldrich
Product number
R134
Product name
Rilmenidine hemifumarate salt
Purity
solid
Packaging
25mg
Price
$562
Updated
2024/03/01
Cayman Chemical
Product number
16988
Product name
Rilmenidine (hemifumarate)
Purity
≥98%
Packaging
1mg
Price
$40
Updated
2024/03/01
Cayman Chemical
Product number
16988
Product name
Rilmenidine (hemifumarate)
Purity
≥98%
Packaging
5mg
Price
$98
Updated
2024/03/01
Cayman Chemical
Product number
16988
Product name
Rilmenidine (hemifumarate)
Purity
≥98%
Packaging
10mg
Price
$161
Updated
2024/03/01
More
Less

RILMENIDINE HEMIFUMARATE SALT Chemical Properties,Usage,Production

Uses

Rilmenidine hemifumarate ┬аis an antihypertensive agent that selectively binds nonadrenergic imidazoline-binding site I1 receptor.

Biological Activity

rilmenidine is an antihypertensive agent that has been shown to lower arterial pressure in various animal models by inhibiting the tonic activity of sympathoexcitatory neurons in the rostral ventrolateral medulla [1].

Biochem/physiol Actions

Selective I1 imidazoline receptor agonist.

in vitro

bilateral microinjection of rilmenidine into the c1 area of the rostral ventrolateral medulla (rvl) elicited dose-dependent falls in arterial pressure and heart rate. in rvl, rilmenidine competed with binding to imidazole and α2-adrenergic binding sites with a 30-fold selectivity for the imidazole binding sites [2]. rilmenidine, a new antihypertensive agent, appeared 2.5 and 3.5 times more selective than clonidine and guanfacine, respectively, for medullary ipr sites than for cortical α-adrenoceptors [3]. rilmenidine targeted the nonadrenergic imidazoline-binding site i1 receptor with the ki value of 7.1 nm and demonstrated weaker affinity for the i2 receptor with the ki value of 5.2 μm [4].

in vivo

in rat model of hypertension associated with insulin resistance, rilmenidine ameliorated the deleterious effects of a high-fructose diet, such as weight gain, hypertension, and resistance to the effects of insulin [5]. in a mouse model of huntington's disease, rilmenidine induced autophagy, attenuated toxicity of polyglutamine expansions and the signs of disease, reduced the mutant huntingtin fragment levels [6].

storage

Store at -20°C

References

[1] reis, d. j. and piletz, j.e. the imidazoline receptor in control of blood pressure by clonidine and allied drugs. american journal of physiology 273(5 pt 2), r1569-r1571 (1997).
[2] gomez r e, ernsberger p, feinland g, et al. rilmenidine lowers arterial pressure via imidazole receptors in brainstem c1 area[j]. european journal of pharmacology, 1991, 195(2): 181-191.
[3] bricca g, dontenwill m, molines a, et al. rilmenidine selectivity for imidazoline receptors in human brain[j]. european journal of pharmacology, 1989, 163(2): 373-377.
[4] guyenet p g. is the hypotensive effect of clonidine and related drugs due to imidazoline binding sites [j]. american journal of physiology-regulatory, integrative and comparative physiology, 1997, 273(5): r1580-r1584.
[5] penicaud l, berthault m f, morin j, et al. rilmenidine normalizes fructose-induced insulin resistance and hypertension in rats[j]. journal of hypertension. supplement: official journal of the international society of hypertension, 1998, 16(3): s45-9.
[6] rose c, menzies f m, renna m, et al. rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of huntington's disease[j]. human molecular genetics, 2010, 19(11): 2144-2153.

RILMENIDINE HEMIFUMARATE SALT Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

RILMENIDINE HEMIFUMARATE SALT Suppliers

ShangHai Caerulum Pharma Discovery Co., Ltd.
Tel
18149758185 18149758185
Email
sales-cpd@caerulumpharma.com
Country
China
ProdList
3466
Advantage
58
Sigma-Aldrich
Tel
021-61415566 800-8193336
Email
orderCN@merckgroup.com
Country
China
ProdList
51456
Advantage
80
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Fax
021-65675885
Email
info@efebio.com
Country
China
ProdList
9806
Advantage
58
Beijing Jin Ming Biotechnology Co., Ltd.
Tel
010-60605840 18892239720
Fax
010-60605840
Email
psaitong@jm-bio.com
Country
China
ProdList
12306
Advantage
58
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
Tel
18818260767
Fax
QQ 3610331285
Email
sales@chemegen.com
Country
China
ProdList
11218
Advantage
58
ShangHai ChuanQian Chemcial Technique Centre
Tel
15869524721
Email
3525679403@qq.com
Country
China
ProdList
4006
Advantage
58
Energy Chemical
Tel
021-58432009 400-005-6266
Fax
021-58436166
Email
marketing@energy-chemical.com
Country
China
ProdList
44918
Advantage
58
Beijing Jin Ming Biotechnology Co., Ltd.
Tel
010-60605840 15801484223;
Email
psaitong@jm-bio.com
Country
China
ProdList
29774
Advantage
58
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com
Country
China
ProdList
24644
Advantage
58
Shenyang Zhongshen Zekang Biomedical Technology Research Co., Ltd
Tel
024-024-88590548 18341751992
Email
757984502@qq.com
Country
China
ProdList
891
Advantage
58
Shanghai Aladdin Biochemical Technology Co.,Ltd.
Tel
+86-18521732826
Email
market@aladdin-e.com
Country
China
ProdList
48461
Advantage
58
Jiangsu Aikon Biopharmaceutical R&D Co.,Ltd.
Tel
025-66061636 18013972705
Email
qqyang@aikonchem.com
Country
China
ProdList
10238
Advantage
58
Guangdong Wengjiang Chemical Reagent Co.,Ltd.
Tel
0751-2815983 13927872582
Fax
0751-2886750
Email
3008325437@qq.com
Country
China
ProdList
3876
Advantage
58
Tel
58896805
Email
7993601name@qq.com
Country
CHINA
ProdList
15620
Advantage
58
Shenyang Zhongshen Zekang Biomedical Technology Research Co., Ltd
Tel
+86-18341751992 +86-15382112998
Email
757984502@qq.com
Country
China
ProdList
892
Advantage
58
Hangzhou MolCore BioPharmatech Co.,Ltd.
Tel
+86-057181025280; +8617767106207
Fax
0571-85806285
Email
sales@molcore.com
Country
China
ProdList
49734
Advantage
58
Shanghai Hao Zhun Biological Technology Co., Ltd.
Tel
--
Fax
--
Email
info@zzsrm.com
Country
CHINA
ProdList
6650
Advantage
58
Guangzhou WeiBo Chemical Co., Ltd.
Tel
--
Fax
--
Email
weibochem@163.com
Country
China
ProdList
6187
Advantage
67

207572-68-7, RILMENIDINE HEMIFUMARATE SALTRelated Search:


  • RILMENIDINE HEMIFUMARATE SALT
  • n-(dicyclopropylmethyl)-4,5-dihydro-2-oxazolamine hemifumarate salt
  • Oxaminozoline hemifumarate salt, Rilmenidene hemifumarate salt, N-(Dicyclopropylmethyl)-4,5-dihydro-2-oxazolamine hemifumarate salt
  • LZFATBMLSYHRTC-WXXKFALUSA-N
  • 207572-68-7
  • C24H36N4O6
  • C10H16N2O12C4H4O4